Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × Psilocybin × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Pain 1 Osteosarcoma 1 Lymphoma 1 Endocrine Gland Neoplasms 1 Depression 1 Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 2 Therapeutics 1 Restraint, Physical 1 Psilocybin 1 Pharmacogenomic Testing 1 Mindfulness-Based Stress Reduction 1 Midazolam 1 Ketamine 1 Eye Movement Desensitization Reprocessing 1 Anesthesia, Local 1 Analgesia 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00979693 2023-12-26

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Multidisciplinary Association for Psychedelic Studies

Phase 2 Withdrawn

Anxiety Disorders, Depression, Melanoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡